Gebelikte Astım ve Diğer Solunum Yolları Hastalıkları
Özet
Referanslar
Matsuzaki H, Matsuzaki S, Ueda Y, Fukuda K, Matsuzaki S, Hiramatsu K, et al. Obesity and asthma during pregnancy: a systematic review and meta-analysis, European Respiratory Review, 2025; 11;34(176):240259.
Schatz M, Dombrowski MP, Wise R, et al. Asthma morbidity during pregnancy can be predicted by severity classification, Journal of Allergy and Clinical Immunology, 2003;112(2):283–288.
Grosso A, Locatelli F, Gini E, Albicini F, Tirelli C, Cerveri I and Corsico AG. The course of asthma during pregnancy in a recent, multicase–control study on respiratory health, Allergy Asthma Clin Immunol, 2018;14:16, doi.org/10.1186/s13223-018-0242-0.
Yıldırım ZB. Gebelik ve Astım, Güncel Göğüs Hastalıkları Serisi 2020; 8 (2): 99-107.
Astım Tanı ve Tedavi Rehberi, Astımın Kronik Tedavisi, Basamak Tedavisi, 2022 Güncellemesi, https://www.aid.org.tr/wp-content/uploads/2022/05/Kronik-Tedavide-Basamak-Tedavisi-2021.pdf.
Global strategy for asthma management and prevention, GINA 2024 Main Report WMS 1, https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf.
Lieberman J. “Should we encourage allergen immunotherapy during pregnancy?” Expert Review of Clinical Immunology 2014; 10: 317-9.
Astım Tanı ve Tedavi Rehberi 2020 Güncellemesi, https://www.aid.org.tr/wp-content/uploads/2020/12/astim-rehberi-2020.pdf.
Wang H, Li N, Huang H. Asthma in Pregnancy: Pathophysiology, Diagnosis, Whole-Course Management, and Medication Safety, Can Respir J. 2020 Feb 22;2020:9046842, doi: 10.1155/2020/9046842.
Murphy V E, Jensen M E, Gibson P G. Asthma during pregnancy: exacerbations, management, and health outcomes for mother and infant. Seminars in Respiratory and Critical Care Medicine. 2017;38(2):160–173. doi: 10.1055/s-0037-1600906.
Kher S, Mota P. Maternal asthma: management strategies. Cleveland Clinic Journal of Medicine. 2017;84(3):296–302. doi: 10.3949/ccjm.84a.15046.
Kelly W, Massoumi A, Lazarus A Asthma in pregnancy: Physiology, diagnosis, and management Postgraduate Medicine, 2015; 127:4, 349-358.
Eltonsy S, Forget A, and Blais L. “Beta2-agonists use during pregnancy and the risk of congenital malformations,” Birth Defects Research Part A: Clinical and Molecular Teratology, 2011, vol. 91, no. 11, pp. 937–947.
Middleton PG, Gade EJ, Aguilera C, et al. ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur Respir J., 2020; 55.
Larivée N, Chin CJ. Aspirin desensitization therapy in aspirin-exacerbated respiratory disease: A systematic review. Int Forum Allergy Rhinol 2020;10: 450-64.
Nelsen LM, Shields KE, Cunningham ML, et al., “Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications,” Journal of Allergy and Clinical Immunology, 2012; vol. 129, no. 1, pp. 251–254.
Kiernan E. and Jones K L, “Medications that cause fetal anomalies and possible prevention strategies,” Clinics in Perinatology, 2019; vol. 46, no. 2, pp. 203–213.
Scurek M., Brat K. A narrative review of theophylline: is there still a place for an old friend?, Journal of Thoracic Disease, 2024; Vol 16, No 5.
Couillard S, Jackson D J , Pavord Ian D, Wechsler ME. Choosing the Right Biologic for the Right Patient With Severe Asthma, Chest. 2025 Feb;167(2):330-342.
Namazy J, Cabana MD, Scheuerle AE, et al. “The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy,” Journal of Allergy and Clinical Immunology, 2015; 135: 407-12.
Abramowicz M, Zuccotti G, and Pflomm JM. Benralizumab (Fasenra) for severe eosinophilic asthma, JAMA: e Journal of the American Medical Association, 2018; vol. 319, no. 14, pp. 1501-1502.
Bonham C, Patterson KC, Strek ME Asthma Outcomes and Management During Pregnancy Chest 2018; 153(2):515-527.
Chambers CD, Krishnan JA, Alba L,et. al. The safety of asthma medications during pregnancy and lactation: Clinical management and research priorities, J Allergy Clin Immunol, 2021; Jun;147(6):2009-2020.
Haines A J, Middleton PG. Pulmonary disorders in pregnancy: Bronchiectasis, cystic fibrosis, sarcoidosis and interstitial diseases, Best Practice & Research Clinical Obstetrics and Gynaecology, 2022; 85:114e126.
Goss CH, Rubenfeld GD, Otto K, Aitken ML. The effect of pregnancy on survival in women with cystic fibrosis, Chest, 2003; Oct;124(4):1460-8.
Stone S, Nelson-Piercy C. Respiratory disease in pregnancy, Obstet Gynaecol Reprod Med. 2007; May 7;17(5):140–146.
Gen M, Antenatal care for pregnant women with Chronic Obstructive Pulmonary Disease (COPD), Int J Respir Med, 2023; https://www.alliedacademies.org/international-journal-of-respiratory-medicine.
Yuliang Zhao, Fei Li, Yangwen Liu, et.al. Comparison of efficiency of inhaled and intravenous corticosteroid on pregnant women with COPD and the effects on the expression of PCT and hs-CRP, Exp Ther Med., 2018; Jun; 15(6): 4717–4722.
Panettieri Jr RA, Kraft M, Castro M, et.al. Efficacy of Biologics in Reducing Exacerbations Requiring Hospitalization or an Emergency Department Visit in Patients with Moderate or Severe, Uncontrolled Asthma, Adv Ther., 2025; 42:2679–2689.